Haemostatic reference intervals in pregnancy

Summary

Haemostatic reference intervals are generally based on samples from non-pregnant women. Thus, they may not be relevant to pregnant women, a problem that may hinder accurate diagnosis and treatment of haemostatic disorders during pregnancy. In this study, we establish gestational age-specific reference intervals for coagulation tests during normal pregnancy. Eight hundred one women with expected normal pregnancies were included in the study. Of these women, 391 had no complications during pregnancy, vaginal delivery, or postpartum period. Plasma samples were obtained at gestational weeks 13–20, 21–28, 29–34, 35–42, at active labor, and on postpartum days 1 and 2. Reference intervals for each gestational period using only the uncomplicated pregnancies were calculated in all 391 women for activated partial thromboplastin time (aPTT), fibrinogen, fibrin D-dimer, antithrombin, free protein S, and protein C and in a subgroup of 186 women in addition for prothrombin time (PT), Owren and Quick PT, protein S activity, and total protein S and coagulation factors II, V, VII, VIII, IX, X, XI, and XII. The level of coagulation factors II, V, X, XI, XII and antithrombin, protein C, aPTT, PT remained largely unchanged during pregnancy, delivery, and postpartum and were within non-pregnant reference intervals. However, levels of fibrinogen, D-dimer, and coagulation factors VII, VIII, and IX increased markedly. Protein S activity decreased substantially, while free protein S decreased slightly and total protein S was stable. Gestational age-specific reference values are essential for the accurate interpretation of a subset of haemostatic tests during pregnancy, delivery, and puerperium.

Keywords

Fibrin D-dimer - haemostasis - normal pregnancy - protein C - protein S - reference interval

• References

• 1 Hellgren M. Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 2003; 29: 125-130.
• 2 Brenner B. Haemostatic changes in pregnancy. Thromb Res 2004; 114: 409-414.
• 3 O’Riordan MN, Higgins JR. Haemostasis in normal and abnormal pregnancy. Best Pract Res Clin Obstet Gynaecol 2003; 17: 385-396.
• 4 Franchini M. Haemostasis and pregnancy. Thromb Haemost 2006; 95: 401-413.
• 5 Abbassi-Ghanavati M, Greer LG, Cunningham FG. Pregnancy and laboratory studies: a reference table for clinicians. Obstet Gynecol 2009; 114: 1326-1331.
• 6 Handbook of clinical laboratory testing during pregnancy. Gronowski A (ed) Totowa: Humana Press; 2004
• 7 Horowitz GL, Altaie S, Boyd JC. et al. Defining, Establishing, and Verifying Reference Intervals in the Clinical Laboratory; Approved Guideline, C28A3E. Third Ed. Wayne: Clinical and Laboratory Standards Institute; 2008
• 8 Klajnbard A, Szecsi PB, Colov NP. et al. Laboratory reference intervals during pregnancy, delivery and the early postpartum period. Clin Chem Lab Med 2010; 48: 237-248.
• 9 Solberg HE. The IFCC recommendation on estimation of reference intervals. The RefVal program. Clin Chem Lab Med 2004; 42: 710-714.
• 10 Bellart J, Gilabert R, Miralles RM. et al. Endothelial cell markers and fibrinopep-tide A to D-dimer ratio as a measure of coagulation and fibrinolysis balance in normal pregnancy. Gynecol Obstet Invest 1998; 46: 17-21.
• 11 Faught W, Garner P, Jones G. et al. Changes in protein C and protein S levels in normal pregnancy. Am J Obstet Gynecol 1995; 172: 147-150.
• 12 Choi JW, Pai SH. Tissue plasminogen activator levels change with plasma fibrinogen concentrations during pregnancy. Ann Hematol 2002; 81: 611-615.
• 13 Uchikova EH, Ledjev II. Changes in haemostasis during normal pregnancy. Eur J Obstet Gynecol Reprod Biol 2005; 119: 185-188.
• 14 Persson KE, Hillarp A, Dahlback B. Analytical considerations for free protein S as-says in protein S deficiency. Thromb Haemost 2001; 86: 1144-1147.
• 15 Lijfering WM, Mulder R, Ten Kate MK. et al. Clinical relevance of decreased free protein S levels: results from a retrospective family cohort study involving 1143 relatives. Blood 2009; 113: 1225-1230.
• 16 Clark P, Brennand J, Conkie JA. et al. Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy. Thromb Haemost 1998; 79: 1166-1170.
• 17 Stirling Y, Woolf L, North WR. et al. Haemostasis in normal pregnancy. Thromb Haemost 1984; 52: 176-182.
• 18 Hellgren M, Blomback M. Studies on blood coagulation and fibrinolysis in pregnancy, during delivery and in the puerperium. I. Normal condition. Gynecol Obstet Invest 1981; 12: 141-154.
• 19 Muller-Berghaus G, Moeller RM, Mahn I. Fibrinogen turnover in pregnant rabbits during the first and last thirds of gestation. Am J Obstet Gynecol 1978; 131: 655-660.
• 20 Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clin Chem 2005; 51: 825-829.
• 21 Chan WS, Chunilal S, Lee A. et al. A red blood cell agglutination D-dimer test to exclude deep venous thrombosis in pregnancy. Ann Intern Med 2007; 147: 165-170.
• 22 Eichinger S. Diagnostic issues of VTE in pregnancy. Thromb Res 2009; 123 (Suppl. 02) S38-S40.
• 23 Chunilal SD, Bates SM. Venous thromboembolism in pregnancy: diagnosis, management and prevention. Thromb Haemost 2009; 101: 428-438.